# A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis

> **NCT01299181** · PHASE4 · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 60 (actual)

## Conditions studied

- Bronchiectasis

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT01299181
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01299181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01299181, "A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01299181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*